One of the known effects of the MOTS-c peptide is related to metabolism. MOTS-c is considered one of the key molecules responsible for regulating metabolism and supporting its improvement.
10,500 UAH
Orders are processed and handed over for delivery within 1–2 business days after confirmation by a manager. We deliver throughout Ukraine with Nova Poshta to a branch, parcel locker, or by courier to your address. Delivery cost is calculated at the carrier’s rates upon receipt.
Payment: Pay on delivery · Card transfer · Bank transfer · Crypto wallet · PayPal
Cagrilintide 10 mg is a novel synthetic analogue of amylin, a hormone produced together with insulin that regulates appetite, slows gastric emptying and contributes to weight control.
It activates specific amylin receptors in the central nervous system, produces a feeling of satiety, reduces calorie intake and has a synergistic effect with GLP-1 agonists.
Suitable for weekly subcutaneous injections
Combines effectively with semaglutide to achieve optimal weight-loss results
Cagrilintide acts through several key mechanisms:
Suppresses appetite by activating central amylin receptors.
Slows gastric emptying and prolongs the feeling of satiety
Reduces food cravings and delays the start of eating
Improves glycemic control and insulin sensitivity.
Tolerability and pharmacokinetics Excellent tolerability with weekly use. Results I Tolerability and pharmacokinetics Excellent tolerability with weekly use. II Efficacy as monotherapy With monotherapy, weight loss is approximately 10-15%. III Combination with semaglutide Weight loss of up to 17.1% (SURMOUNT-3) with concomitant therapy.
Weight loss of up to 15% (when used as monotherapy)
Weight loss of up to 17-20% in combination with semaglutide
Appetite suppression and a feeling of satiety with smaller portions
Control over overeating
Improved lipid and glucose profiles
Simple administration, subcutaneously once a week
Safety has been studied clinically
Use:
Frequency: once a week on the same day.
Add 3.0 ml of bacteriostatic water to the vial → concentration approximately 3.33 mg/ml.
Simple measurement: at a concentration of 3.33 mg/ml, one unit = 0.01 ml ≈ 0.0333 mg (33.3 mcg) on a U-100 insulin syringe.
Week/Phase Weekly dose (mg)
Weeks 1-2 0.6 mg 18 units 0.18 ml
Weeks 3-4 1.2 mg 36 units 0.36 ml
Weeks 5-6 2.4 mg 72 units 0.72 ml
Weeks 7-16 (maintenance) 4.5 mg 135 units 1.35 ml
After reconstitution, store in a refrigerator at 2-8 °C (do not freeze)
As with most peptide receptor agonists, some users may experience the following temporary and minor adverse effects:
Nausea, constipation and diarrhea in 41-63% of patients, mainly at the beginning of the condition.
Injection-site irritation, a common and mild effect.
Rarely: headache, fatigue and a slight increase in heart rate.
Warning! The information on this website is provided for reference only; the product is not a medicinal product. The appearance of the packaging may be changed by the manufacturer without notice.
The product is intended for research purposes only, not for human use. The information was collected through numerous studies and analyses conducted over many years and is not intended for the diagnosis, treatment or prevention of any disease.
*All results are individual and depend on your health status
| Active ingredient | Cagrilintide |
|---|---|
| Product form | Powder in a vial |
| Dosage | 10 mg |
| Route of administration | Subcutaneous injection |
| Requires reconstitution | Yes |
| Storage conditions | 2–8 °C (refrigerated) |
Кагрилінтид 10 мг – це інноваційний синтетичний аналог аміліну – гормону, що виробляється разом з інсуліном, який регулює апетит, уповільнює спорожнення шлунка та сприяє контролю ваги. Він активує специфічні рецептори аміліну в центральній нервовій системі, викликає відчуття ситості, знижує споживання калорій та має синергічний ефект з агоністами GLP-1. • Підходить для щотижневих підшкірних ін'єкцій • Ефективно поєднується з семаглутидом для досягнення оптимальних результатів у зниженні ваги
Кагрилінтид діє за допомогою кількох ключових механізмів: • Пригнічує апетит, активуючи центральні рецептори аміліну. • Уповільнює спорожнення шлунка та продовжує відчуття ситості • Зменшує потяг до їжі та пізній початок прийому їжі • Покращує глікемічний контроль та чутливість до інсуліну.